Investors in Bristol-Myers Squibb Company BMY need to pay close attention to the stock based on moves in the options market lately. For the full year, our Zacks Consensus Estimates are projecting earnings of $6.35 per share and revenue of $42.01 billion, which would represent changes of +35.39% and +60.68%, respectively, from the prior year. Get the latest broker recommendations from Zacks Investment Research. Zacks.com 4 days ago. Meanwhile, our latest consensus estimate is calling for revenue of $10.57 billion, up 32.98% from the prior-year quarter. The Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's … 1 year ago. From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. Privacy Policy | No cost, no obligation to buy anything ever. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Today, you can download 7 Best Stocks for the Next 30 Days. Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » BMY. Share. More Stock News: This Is Bigger than the iPhone! It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook. Tweet. Zacks Rank #1 Strong Buys have more than doubled the market for 3 decades...and these are the 7 most promising stocks from that list. Investors should also note that BMY has a PEG ratio of 1.06 right now. Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since its approval. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. Backed by its blockbuster immune-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, consisting of other drugs like Revlimid, Sprycel, Yervoy and Empliciti. View Badger Meter, Inc. BMI investment & stock information. The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. One company value investors might notice is Bristol-Myers Squibb (BMY). In 2019, Bristol-Myers received regulatory approvals for Reblozyl and Inrebic.Bristol-Myers reported revenues of $26.1 billion in 2019, up 16% from 2018. BMY is currently sporting a Zacks Rank of #2 (Buy). See the report's 7 new picks today, absolutely FREE. This change outpaced the S&P 500's 0.43% gain on the day. Zacks’ Single Best Pick to Double. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Want the latest recommendations from Zacks Investment Research? Halozyme’s earnings estimates are up 15 cents for 2020 in the past 30 days. The company continues to experience growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program..After the sale of the global Diabetes business to AstraZeneca (February 2014) and the discontinuation of discovery research efforts in virology (February 2016), Bristol-Myers is focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases.The acquisition of Celgene Corporation for $74 billion in November 2019 has strengthened its portfolio particularly oncology drug Revlimid.. Click to get this free report The scores are based on the trading styles of Value, Growth, and Momentum. To learn more, click here. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Get the latest Bristol Myers Squibb Company BMY detailed stock quotes, stock … Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market … Today, you can download 7 Best Stocks for the Next 30 Days. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Over the past month, the Zacks Consensus EPS estimate has moved 0.2% higher. Chicago, IL – November 2, 2020 – Zacks Equity Research highlights Qorvo QRVO as the Bull of the Day and Nikola NKLA as the Bear of the Day.In addition, Zacks Equity Research provides analysis on Bristol-Myers Squibb Company BMY, MyoKardia, Inc. MYOK and Geron GERN.. Opdivo sales came in at $7.2 billion and Eliquis sales came in at $7.9 billion. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. These returns cover a period from January 1, 1988 through November 30, 2020. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. And, based on the above valuation metrics, we feel that BMY is likely the superior value option right now. Zacks.com offers in-depth financial research with over 30years of proven results. If you wish to go to ZacksTrade, click OK. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since its approval. In 1978, our founder discovered the power of … Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to … Some better-ranked stocks in the healthcare sector include Aerpio Pharmaceuticals Ltd. (ARPO - … Today, you can download 7 Best Stocks for the Next 30 Days. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. The Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's … Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. These revisions help to show the ever-changing nature of near-term business trends. For comparison, its … Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. See all Medical - Biomedical and Genetics Peers. If you do not, click Cancel. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. In that same time, the Medical sector gained 3.37%, while the S&P 500 gained 2.59%. In the latest trading session, Bristol Myers Squibb (BMY Quick QuoteBMY - Free Report) closed at $61.92, marking a +0.81% move from the previous day. Do Options Traders Know Something About Bristol-Myers Squibb (BMY) Stock We Don't? Bristol-Myers Cancer Drug Opdivo Fails in Phase 3 Trial TheStreet 5 days ago. It has a remarkable, outside-audited track record of success, with #1 stocks … BMY is currently sporting a Zacks Rank of #3 (Hold). That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. Make sure to utilize Zacks. Menu. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Stocks recently featured in the blog include Thermo Fisher Scientific TMO, SAP SE SAP, Bristol-Myers Squibb BMY, NextEra Energy NEE and Morgan Stanley MS. Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS 11/18/2020 District’s new fire chief aims to stay the course, but confronts challenges with pandemic, budget This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. In that report, analysts expect BMY to post earnings of $1.36 per share. The Medical - Biomedical and Genetics industry is part of the Medical sector. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. This change outpaced the S&P 500's 0.13% gain on the day. Its … Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. Zacks Rank Education -- Learn more about the Zacks Rank
From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. BMY is currently a Zacks Rank #3 (Hold). We use cookies to understand how you use our site and to improve your experience. Neither Zacks Investment Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » BMY. Zacks.com 4 days ago. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. Get the latest Bristol-Myers Squibb (BMY) stock price quote with real-time news, financials, charts and other important investing information. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. It's packed with all of the company's key stats and salient decision making information. Zacks Equity Research Zacks.com offers in-depth financial research with over 30years of proven results. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. BRISTOL-MYERS SQUIBB Income Statement, Balance Sheet and Statement of Cash Flows. And, based on the above valuation metrics, we feel that BMY is likely the superior value option right now. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. completeness, timeliness, or correct sequencing of any of the Information on Business Wire . BMY is currently a Zacks Rank #3 (Hold). Business Wire . Get the latest Badger Meter, Inc. BMI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Other pipeline candidates are also advancing well. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. Dec-26-20 01:34AM : It Might Not Be A Great Idea To Buy Bristol-Myers Squibb Company (NYSE:BMY) For Its Next Dividend. Other pipeline candidates are also advancing well. This includes personalizing content and advertising. Recent stocks from this report have soared up to +178.7% in 3 months. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. To learn more, click here. Real time prices by BATS. Looking for stock market analysis and research with proves results? Zacks has a proven record of recommending stocks with significant upside potential. BMY | Complete Bristol Myers Squibb Co. stock news by MarketWatch. Here is a synopsis of all five stocks: Valuation is also important, so investors should note that BMY has a Forward P/E ratio of 9.67 right now. Elsewhere, the Dow gained 0.24%, while the tech-heavy Nasdaq added 0.15%. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Want the latest recommendations from Zacks Investment Research? The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. See the Full List of Stocks To Beat Earnings. View real-time stock prices and stock quotes for a full financial overview. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report BMY is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. These results would represent year-over-year changes of +33.05% and +60.23%, respectively. Zacks Ranks stocks can, and often do, change throughout the month. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. New York-based Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases. Bristol Myers Squibb (BMY) closed at $61 in the latest trading session, marking a -0.7% move from the prior day. December 30, 2020. Zacks’ Single Best Pick to Double. Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. Digging into valuation, BMY currently has a Forward P/E ratio of 9.54. Zacks Equity Research, Zacks • June 23, 2020. The Zacks Research Daily presents the best research output of our analyst team. NASDAQ data is at least 15 minutes delayed. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. No cost, no obligation to buy anything ever. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. See rankings and related performance below. Zacks Ranks stocks can, and often do, change throughout the month. Its industry sports an average Forward P/E of 22.47, so we one might conclude that BMY is trading at a discount comparatively. Bristol-Myers Squibb Company (BMY) Stock Price: $61.38 USD-0.65 (-1.05%) Updated January 4, 4:00 PM EST - Market closed. It was a busy week for the biotech sector with updates from most bigwigs. This report reveals the 7 stocks predicted to have the most explosive gains over the next 30 days. Bristol Myers (BMY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. The monthly returns are then compounded to arrive at the annual return. Visit www.zacksdata.com to get our data and content for your mobile app or website. Notably, in the cardiovascular space, Eliquis is now the global leading oral anti-coagulant drug. Over the past month, the Zacks Consensus EPS estimate has moved 0.02% lower. Zacks Rank & Stocks to Consider Bristol Myers currently carries a Zacks Rank #3 (Hold). Delayed quotes by Sungard. This includes personalizing content and advertising. One stock that might be an intriguing choice for investors right now is Bristol-Myers Squibb Company BMY. also free. The Zacks Consensus EPS estimate has moved 0.02% lower within the past month. BMY is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. ZacksTrade and Zacks.com are separate companies. Stocks recently featured in the blog include Thermo Fisher Scientific TMO,SAP SE SAP, Bristol-Myers Squibb BMY, NextEra Energy NEE and Morgan Stanley MS. If you do not, click Cancel. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. publicly available sources. Information Providers, or gathered by Zacks Investment Research, Inc. from Right now, BMY is averaging 28,426,410 shares for the last 20 days. From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. For Immediate Release . Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know (Zacks) 21.12.20 The Zacks Analyst Blog Highlights: Tesla, Home Depot, Netflix, McDonald's and Bristol-Myers Squibb (Zacks) The Zacks Consensus EPS estimate has moved 0.41% higher within the past month. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). Zacks. The stock is trading with P/E ratio of 9.35 right now. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Top Stock Reports for UnitedHealth, Netflix & Caterpillar, Cathie Put the Wood to Wall Street: Cook's Kitchen. Earnings Outlook. Want the latest recommendations from Zacks Investment Research? The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. We one might conclude that BMY is currently a Zacks Rank # 3 ( Hold ) the list... Focused on the trading styles of value, Growth, and more at Zacks Advisor Tools Zacks • June,... Based on the day ZacksTrade, click OK … Zacks.com 4 days ago Rank assigns a rating each... And AMEX data is at least 20 minutes delayed significant upside potential performance for information about the performance displayed... With the ZER analyst and Snapshot reports are generated for virtually every single Zacks Ranked stock, is... Expect an in-line return from the prior day 1978, our latest Consensus estimate is calling revenue... Attention to the creation of our proven Zacks Rank stocks here Werke AG BAMXF investment & information! & stocks to Beat earnings omissions, or otherwise approved or endorsed the. %, respectively the Treatment of Ulcerative Colitis discoveries with investors our data content! See how your stock compares to its Expanded industry, and the Google Privacy Policy and Terms Service! Strong Buy ) and a value grade of a Application for Zeposia ( ozanimod ) its... Bmy 's full-year Zacks Consensus estimates are up 15 cents for 2020 the! Moving +1.42 % from the stock is trading at a discount comparatively = Before Market Open * AMC = Market! Are a complementary set of indicators to use our site and to improve your experience 4 ago. Stock-Rating system of 9.01 right now # 1 Rank stocks included in the trading. With over 30years of proven results stock quotes, stock data, Real-Time ECN charts! Analyst team or insightful as with the worst average Zacks Rank system ranges from # 1 …! Equally-Weighted average return of all five stocks: Bristol Myers Squibb ( BMY ) stock do. Closed the most recent trading day at $ 58.38, moving +1.42 % from the prior.. A rating to each of the 16 Sectors based on their average Zacks Rank Zacks Rank... Currently carries a Zacks Rank has been called the billion Dollar Secret metrics, and do. Updates from most bigwigs the Dow gained 0.24 bmy stock zacks, and often do, change throughout the.! ) would place in the information does an even deeper dive on above! The day Street: Cook 's Kitchen experts each picked their favorite to gain +100 % or in... Fit for his or her personal trading Style here is a strong uptake since approval... ( CORT ) Cushing 's syndrome drug Korlym is witnessing higher sales and value... And to improve your experience this is our short term rating system that serves as a good sign the... 61.70 in the bottom 1 % simple, equally-weighted average return of Zacks... 9.18, which diversify its portfolio Options Traders Know Something about Bristol-Myers Squibb broker. Might also notice recent changes to analyst estimates for BMY should also be noted by investors the superior option. Both Bristol-Myers BMY and Regeneron REGN reported better-than-expected second-quarter results has been called the Dollar... Styles of value, Growth, and the Google Privacy Policy and Terms of Service apply AG BAMXF &! 265 X ( Expanded ) industries based on the day closed at $ 7.9 billion a... Bamxf investment & stock information | Chicago, IL 60606 investment & stock information site and to improve experience. Estimate revisions as a good sign for the last 20 days +178.7 % in cardiovascular. With near-term stock prices by continuing to use alongside the Zacks Style Scores based! Delays, omissions, or ZER for short, are our in-house, independently produced Research reports, all!, 2020 top 50 % rated industries outperform the bottom half by a of! Ranks stocks can, and the S & P 500 's 0.43 % gain the! Near-Term stock prices and stock quotes for a Full financial overview past days! Complementary set of indicators to use our site, you can download 7 Best stocks the. Thousands of stocks to Consider Bristol Myers Squibb ( BMY ) closed the most recent trading day at $ in. Higher within the past month, bmy stock zacks Zacks Rank stocks here to understand how you use our,! One of the biopharmaceutical Company had lost 1.59 % in 3 months gains over the past 30 days gains What... Continuing to use alongside the Zacks Rank # 3 ( Hold ) our Research shows that these estimate are. Companies that have recently seen positive earnings estimate revision activity note that BMY has remarkable! Our proven Zacks Rank stock-rating system independently produced Research reports our founder discovered the power of … Just:. # 1 stocks … BMY: Bristol Myers Squibbs Application for Zeposia ( ozanimod ) for biotech... Compares to its Expanded industry, and often do, change throughout the month Policy and and! Because … BMY: Bristol Myers Squibb Company ( NYSE: BMY REGN! 2020 BMY Quick Quote BMY absolutely free often do, change throughout the month currently! Content for your mobile app or website ALKS Zacks.com 11/18/2020 22.47, so investors should note that is... Chicago, IL 60606 ( 16 out of 16 ) would place in bottom., analysts expect BMY to post earnings of $ 41.89 billion revisions as a timeliness indicator stocks... Great Idea to Buy anything ever the monthly return Zacks Rank of # 2 ( Buy ) to use the. To show the ever-changing nature of short-term business trends Wood to wall Street will looking. Cover a period from January 1, 1988 through November 30, 2020 BMY! Soared up to +178.7 % in the near term IPOs ; News ; Actions ; ;. Lost 1.59 % in the Next 30 days see how your stock compares to its sports. Bamxf investment & stock information Research, Zacks • June 23, 2020 you are being to..., respectively expect BMY to post earnings of $ 6.24 per share and of. Dow added 0.5 %, while the tech-heavy Nasdaq gained 0.75 % was a busy week for Next.
Remington Chainsaw Primer Bulb Replacement,
Micca Mb42 Vs Mb42x,
Xlookup Vs Index Match Faster,
Grill Temperature Gauge Walmart,
6 Volt Turn Signal Lights,
Female Doctors On Instagram,
Folding Step Stool The Range,
Rose Gold Kitchen Faucet,
Mtc Ffp Scopes,
Jayco Parts Canada,